Home » Topics » BioWorld Science

BioWorld Science
RSS

Caelyx approved in Australia and New Zealand

July 31, 1997

Phase I comparison of CCKA agonist and CCK-8 for effects on satiety

July 31, 1997

Antiobesity drug therapy

July 31, 1997

Clinical pharmacokinetics, safety and efficacy of orlistat

July 31, 1997

Osteoporosis test from Cortecs nearing launch

July 31, 1997

Potential antitumor agents evaluated by Taiwan researchers

July 31, 1997

Antimicrobial DHFR inhibitors from Roche

July 31, 1997

Agents for Parkinson's disease prepared at Rhone-Poulenc Rorer

July 31, 1997

New oral carbapenems with enhanced antibacterial activity

July 31, 1997

HMR discovers elastase inhibitors and prodrugs thereof

July 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...